Human induced pluripotent stem cell-derived cells
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75F40125D00013
- Awardee
-
Fujifilm Biosciences Inc. UEI NCTEKHZJ9293
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 3 $407,083 obligated
Award facts
- Combined order value
- $407,083 Current and potential, with all options
- Last date to order 19% complete
- IDV ceiling 81% used
- $500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Fujifilm Biosciences Inc. on September 3, 2025, for the procurement of human induced pluripotent stem cell-derived cells, with a ceiling of $500,000 and an ultimate completion date of August 31, 2031.
Place of performance is Silver Spring, Maryland. The contract supports FDA's biomedical research operations through firm fixed-price delivery orders for hiPSC cells and related research materials.
Two delivery orders have been issued under this IDIQ. A $246,980 delivery order was awarded on September 10, 2025, with completion scheduled for September 8, 2026. A $15,133 delivery order was awarded on June 1, 2026, with completion scheduled for May 31, 2027. Both orders are priced on a firm fixed-price basis with no set-aside applied.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| EO 14398 - purchase of human induced pluripotent stem cell-derived (hipsc) cells. | Food and Drug Administration | $144,970 | |
| Purchase of human induced pluripotent stem cell-derived (hipsc) cells | Food and Drug Administration | $15,133 | |
| Task order: human induced pluripotent stem cell-derived cells | Food and Drug Administration | $246,980 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Original award | $2,500 |
Quick answers
Who was awarded contract 75F40125D00013?
75F40125D00013 was awarded to Fujifilm Biosciences Inc. by Food and Drug Administration (Department of Health and Human Services) on September 3, 2025.
How much is contract 75F40125D00013 worth?
Orders under 75F40125D00013 have obligated $407,083. 75F40125D00013's own ceiling is $500,000.
How many orders have been placed under contract 75F40125D00013?
3 orders have been placed under 75F40125D00013, the latest on September 30, 2026.
Who can order from contract 75F40125D00013?
75F40125D00013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75F40125D00013 competed?
The extent of competition for 75F40125D00013 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV